Birmingham is the second largest city in the United Kingdom and the University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest teaching hospital trusts in England.
It includes Birmingham Heartlands Hospital, the Queen Elizabeth Hospital Birmingham, Solihull Hospital and Community Services, Good Hope Hospital in Sutton Coldfield and Birmingham Chest Clinic. They see and treat more than 2.2 million people every year across their sites and their hospitals deliver more babies than anywhere else in Europe.
They are a regional centre for cancer, trauma, renal dialysis, burns and plastics, HIV and AIDS, as well as respiratory conditions like cystic fibrosis. They also have expertise in premature baby care, bone marrow transplants and thoracic surgery and have the largest solid organ transplantation programme in Europe. They provide a series of highly specialist cardiac, liver and neurosurgery services to patients from across the UK.
Birmingham are world-renowned for their trauma care and have developed pioneering surgical techniques in the management of ballistic and blast injuries. As a result of its clinical expertise in treating trauma patients and military casualties, the QEHB has been designated both a Level 1 Trauma Centre and host of the UK’s only £20m National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC).
Birmingham has been challenging and developing great minds for more than a century. Characterised by a tradition of innovation, research at the University has broken new ground, pushed forward the boundaries of knowledge and made an impact on people’s lives. Birmingham was named University of the Year 2014 in The Times and The Sunday Times Good University Guide in October 2013. Outstanding performance across the league tables and Birmingham's bold and sector-leading initiatives were recognised by this prestigious accolade.
The vision of the NIHR Birmingham Biomedical Research Centre is to establish a multidisciplinary team of clinicians, nurses, scientists and clinical trials experts that can deliver a Trials Acceleration Programme (TAP) to reduce the time taken to translate scientific discoveries into clinical benefits for patients. Our BRC has an important educational remit, helping to train the next generation of biomedical researchers and to inform and educate the public about advances in medical care for inflammatory diseases.
University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest teaching hospital trusts in England, serving a regional, national and international population.It includes Birmingham Heartlands Hospital, the Queen Elizabeth Hospital Birmingham, Solihull Hospital and Community Services, Good Hope Hospital in Sutton Coldfield and Birmingham Chest Clinic. They see and treat more than 2.2 million people every year across their sites and their hospitals deliver more babies than anywhere else in Europe.
NIHR CLAHRC West Midlands is a five-year initiative funded by the National Institute of Health Research (NIHR) and matched funds provided by local health and social services. The initiative builds on the successful CLAHRC for Birmingham and Black Country pilot with a mission to create lasting and effective partnerships across health and social care organisations, universities (Birmingham, Keele and Warwick) to improve the services they can deliver for patient benefit.
The Birmingham NIHR / Wellcome Trust Clinical Research Facility (CRF) comprises adult and paediatric facilities based at the Queen Elizabeth Hospital and Birmingham Children’s Hospital. The facility provides high-quality clinical environments where patients can take part in experimental and complex clinical research studies.
The West Midlands Academic Health Science Network (WMAHSN) will be pivotal to the generation and maintenance of a healthier region in which there is equitable access to high quality, efficient, effective, person-centred care that delivers the best clinical outcomes and patient satisfaction through the faster adoption of innovation.
The Birmingham ECMC aims to improve the feasibility and quality of research in the areas of immunotherapy and gene therapy, translational genetics and biomarkers.
This work is being conducted in many different types of cancer. The Centre has established bio-repositories, developed antibody-based assays and conducted various immunotherapy/gene therapy trials.